Your browser doesn't support javascript.
loading
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib.
Welsh, Sarah J; Thompson, Nicola; Warren, Anne; Priest, Andrew N; Barrett, Tristan; Ursprung, Stephan; Gallagher, Ferdia A; Zaccagna, Fulvio; Stewart, Grant D; Fife, Kate M; Matakidou, Athena; Machin, Andrea J; Qian, Wendi; Ingleson, Victoria; Mullin, Jean; Riddick, Antony C P; Armitage, James N; Connolly, Stephen; Eisen, Timothy G Q.
Afiliação
  • Welsh SJ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Thompson N; Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Warren A; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Priest AN; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Barrett T; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Ursprung S; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Gallagher FA; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Zaccagna F; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Stewart GD; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Fife KM; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Matakidou A; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Machin AJ; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Qian W; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Ingleson V; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Mullin J; Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Riddick ACP; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Armitage JN; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Connolly S; Cancer Research UK Cambridge Centre Urological Malignancies Programme, University of Cambridge, Cambridge, UK.
  • Eisen TGQ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
BJU Int ; 130(2): 244-253, 2022 08.
Article em En | MEDLINE | ID: mdl-34549873
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Antineoplásicos Limite: Humans Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Antineoplásicos Limite: Humans Idioma: En Revista: BJU Int Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido